NSE filing, NSE: AISL. Summary written from the filing by ALFA Finder's alert engine.
ANI Integrated Services Ltd: key numbers
- Share price
- ₹33.50
- Market cap
- ₹78.30 Cr
- Revenue (annual)
- ₹254.2 Cr
- Net profit (annual)
- ₹5.39 Cr
- P/E (TTM)
- 14.5×Sector 43.1×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ANI Integrated Services Ltd
All →ANI Integrated Services Bonus Issue
ANI Integrated Services Limited allotted 1,16,87,200 bonus shares in a 1:1 ratio. This capitalisation increases the company's total paid-up share capital.
- Value
- ₹11.69 Cr
ANI Integrated Services Bonus Issue
ANI Integrated Services Limited has announced a 1:1 bonus issue of equity shares. This issuance will double the company's paid-up share capital.
ANI Integrated Services Bonus Issue
ANI Integrated Services has fixed October 9, 2026, as the record date for its 1:1 bonus equity share issue. Shareholders approved this issuance previously.
ANI Integrated Services Annual General Meeting
ANI Integrated Services Limited held its 17th Annual General Meeting on September 26, 2026. Shareholders approved all business items, including the final dividend and bonus shares.
ANI Integrated Services Management Change
Mr. Rajendra Gadve has resigned as Non-Executive Independent Director of ANI Integrated Services Limited, effective September 21, 2026, citing personal and professional commitments.
ANI Integrated Services Annual General Meeting
ANI Integrated Services will hold its 17th AGM on September 26, 2026. The agenda includes dividend declaration, authorised capital increase, and a 1:1 bonus issue.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.